Pierre Labbé

All filings by Pierre Labbé on record concern IMV Inc. (formerly Immunovaccine Inc.). Over a trading history stretching from 2 May 2018 to 21 June 2019, the count stands at 18 filings.

Every open-market trade on record is a purchase: 17 purchases worth €130k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2019 to date brings 15 purchases and no sales.

A typical purchase (the median) is worth €8,191. No cluster: in 17 purchases, no other insider of the company bought within 30 days.

The record was last updated on 21 June 2019 with an open-market purchase (€6,832) in IMV Inc. (formerly Immunovaccine Inc.). Half of the filings or more reach the SEDI feed on the day of the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.